Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Hands-Free Rapid Test Detects Bacteria in Fluids

By LabMedica International staff writers
Posted on 03 Dec 2024

Bacteriophages, the most abundant form of life on Earth, are specialized to target and destroy specific types of bacteria. More...

Their natural ability to fight bacteria has long been harnessed to treat infections. Now, researchers have developed a novel test that uses harmless bacteriophages to detect disease-causing bacteria in fluids. This test enables even untrained users to identify bacterial contamination in liquids using a biogel that changes color when exposed to bacteria like E. coli, listeria, and other common pathogens.

The test, developed by a team of engineers and biochemists at McMaster University (Hamilton, ON, Canada) utilizes bacteriophages embedded in a gel to detect bacteria in fluid samples, including urine, even at low concentrations. In the test, the bacteriophages target and attack specific bacteria in the sample. As the bacteria are destroyed, they release small amounts of intracellular material that the test can detect, causing the gel to change color. If no bacteria are present, the color remains unchanged. This process takes just hours to provide results, significantly faster than traditional lab cultures, which can take up to two days. The test, detailed in a paper published in Advanced Materials, is part of a broader effort by researchers to develop simple technologies accessible to consumers, medical professionals, and industries.

The team had previously worked on creating a portable library of tests using phages to combat antibiotic-resistant infections. To validate the new test, the researchers used urine samples from patients at Hamilton Health Sciences, and the results were consistent with those of traditional lab methods. This new test can be customized for any bacteria by utilizing specific bacteriophages and DNA probes targeting microbes like listeria and salmonella. The ability to test complex fluids, such as blood and urine, for contamination is particularly challenging, and the simplicity and reliability of this new test make it a valuable tool. The researchers hope to collaborate with commercial partners to bring this innovation to the market.

“Today, people who suspect they may have a urinary-tract infection must visit a doctor and sometimes wait days for a result. This technology would make it very easy for people to tests themselves at home and get a result in a matter of hours,” said corresponding author Tohid Didar, an associate professor of mechanical and biomedical engineering who holds the Canada Research Chair in Nano-Biomaterials.


New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Portable Electronic Pipette
Mini 96
Capillary Blood Collection Tube
IMPROMINI M3
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.